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the charts for three months. The results of the audits were again 
discussed in staff meetings, leading to the revision of forms that 
"had been around forever". The goal was to make the forms easier 
to complete while assuring the needed information was reproted 
efficiently. Additional meetings with the staff- helped identify 
another challenge. The staff routinely reported problems occuring 
during procedures as "variances", not realizing this was a perfect 
example of Quality hnprovement. Variances are now discussed 
monthly in staff and Quality Improvement meetings and the 
results are trended. Two of the trends identified were brought o 
the attention of the equipment manufacturer. Sharing this infor- 
mation led to the re-design of a machine clip and a warning state- 
ment about hyperlipidemia patients by the companies involved. 
These are just a few of the processes that were already in place; 
the Quality Improvement Plan ahnost wrote itself. Nurses identify 
and solve problems every day. Each time this is done, the quality 
of the practice is improved. So, Interdisciplinary Teams; START 
YOUR BINDERS. 
patient was also performed. As a result, the team developed a
BMT patient education hard cover binder. The goal of the binder 
is to provide up to date, concise, and consistent educational mate- 
rial that travels with the patient across the continuum of care. The 
information contained in the binder is available on the institution- 
al web-site in an effort to pronmte asily accessed information for 
patients and staff. The content of the binder will be incorporated 
into the orientation and continuing education of new and current 
staff. Maintaining the accuracy of the information presented is 
facilitated by the ease in which the informational pages can be 
removed and replaced. The binder is designed with an easy to fol- 
low table of contents and tabulated sections for ease of use. Con- 
tents include an overview of the BMT process, side effects of 
treatment, discharge teaching, care giver information, and outpa- 
tient care. Also included are maps of the area and hospital layout, 
a business card holder, and a glossary of terms. Funding is provid- 
ed by a volunteer endowment created for patient support. A confi- 
dential patient survey is also included, which provides the basis for 
ongoing quality process improvement. 
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TIS THE SEASON TO BE SNEEZING - RSV 
Meyers, A.L; Neumam~, ft. BMT, MD /h~dersom Hom'tom TX.
One of the greatest risks for morbidity and mortality in the 
blood and marrow transplantation (BMT) patients is infection. 
The  risk is high even after engraftment, especially in those 
patients on immunosuppressive th rapy. In our BMT program we 
transplant over 500 patients per year. During the winter months 
of 2001-2002, 63 patients with documented respiratory viral 
infections were reported. Respiratory syncytial virus (RSV) 
accounted for approximately 40% of these cases. RSV is a single 
stranded RNA virus that is endemic in the community, involves 
only the respiratory tract and can remain live for up to 6 hours on 
surfaces. Ninety-four percent of viral infections found in our 
patients could be traced to community sources. The nurses and 
physicians creen for signs and symptoms of upper respiratory 
infection in the clinic prior to BMT scheduled admissions, as well 
as on our 52-bed inpatient BMT unit. A nasal wash and throat 
swab are performed and sent for viral culture and rapid viral anti- 
gen testing for any patient with positive symptoms. Admission 
may be delayed and inpatients are placed on contact isolation if 
suspicion is high or initial results positive. Visitors are also 
screened on the inpatient unit. The treatment of choice for 
patients with a positive RSV infection includes continuous or 
intermittent aerosolized ribavirin with the use of a portable hepa- 
fi ltered tent to lessen exposure of the drug to others. 
[mmunoglobulins are also used to assist the immune system to 
fight the infection. Mortality is very high in patients who develop 
pneumonia, are neutropenic or where treatment is delayed. Our 
current infection control recommendations will be presented, as 
well as aspects of the physical and psychosocial nursing care for 
this potentially life threatening diagnosis and stressful treatment 
regimen. 
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IMPROVING AND STANDARDIZING PATIENT EDUCATION: A 
PATIENT'S RESOURCE GUIDE ACCROSS THE CONTINUUM OF CARE 
FOR BLOOD AND MARROW TRANSPLANTATION 
ffezvell, ft. l SotamseJz, S. 1; Calamusa, ft. t; Ado~,netto, D.1; Ba,ghmml, 
E.Z; [ppoliti, C. l 1. ~I.D. d.de'rson Cancer Ce,ter, Housto~z, TX; 
2. M.D. Anderson Omcer Center, Hom'to~l, TX. 
Providing and maintaining up to date patient education materi- 
als is an ongoing challenge. Solving this dilemma became an iden- 
tified Quality Process Improvement goal for the BMT nursing 
leadership team for 2002. Problems identified by the multi-disci- 
plinary team included out of date, inconsistently available, and 
poorly presented materials. Our task was to look for innovative 
ideas to challenge the way things had always been done. Current 
educational materials were reviewed by the team. A review of the 
literature and evidenced-based practice in the care of the BMT 
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NURSE'S ROLE IN RECOGNIZING AND TREATING "ENGRAFTMENT 
SYNDROME" 
C, msto~, C.A.1; Nemnmm, j.3, lppollitti, C\ s i. Nursing~ 3/iDA,dersoT~ 
c:ancer Center, Ho,ston, TX; 2. 3 lDA~lderson CriTter C nte15 Houston, 
TX; 3. MDAmterso~z Grocer Cellte'G HoustoTz, TX; 4. 3/iDdndevso~ 
Ce~zcer CeTzte'G Hoztsto77, TX. 
Increasingly, nurses play a very important role in early recog- 
nition of signs and symptoms of "engraftment syndrome" (
which some call cytokine storm). If left untreated, it can be a 
serious and fatal complication for Blood and Marrow Trans- 
plantation (BMT) patients. At the time of engraftment, the clay 
preceding or post, many patients may show signs of this phe- 
nmneuon. The signs and symptoms can be a fever up to 40 
degrees C, rash, generalized and puhnonary edema. The respi- 
ratory symptoms can be severe and including diffuse alveolar 
hemorrhage (DAII). The  pat ient  may experience marked 
increase in oxygen needs ranging front room air to 80% non- 
rebreather  mask in a short  period; shortness of  breath,  
increased anxiety,, restlessness, hemoptysis and cough may be 
additional signs. It is critical for the BMT mtrse to understand 
and recognize the risks, as well as signs and symptoms with 
even subtle changes around this period of engraftment. The 
treatment the nurse would anticipate includes: stat high dose 
steroids, typically 500mg to 1Gin for 1-3 days, followed by a 
taper depending on the patient's condit ion; a stat dose of 
diuretic, usually furosemide; and potential antimicrobial therapy 
change. If DAH is suspected, The DAH Standard of Care 
(SOC) would be initiated. Transfer to the intensive care unit 
would occur, if intubation is needed. Topical steroids may be 
ordered for skin rash. It has been demonstrated in many 
patients that this complication may herald the early develop- 
ment of acute graft vs. host disease. The clinical nurse at the 
bedside plays an extremely important role in determining the 
outcome for them patient. 
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ASSESSING LEARNING NEEDS OF STEM CELL TRANSPLANT PATIENTS 
Wood, L.Ld i Rawl, S.Md I. Bone Mmv'ow Tram'plant, lmtim~a Ulli- 
vevs#_y MediLvl Center, Indianapolis, IN," 2. bzdbma University &'hool 
of Nursing, hMiannpolis, IN. 
Rapidly evolving developments in stem cell transplantation 
(SCT) present a challenge to those who educate patients undergo- 
ing this complex therapy. A prospective study using survey meth- 
ods was performed in a 14-bed Stem Cell Transplant Unit in a 
large Midwest teaching hospital. The purpose of the study was to 
assess the learning needs of stem cell transplant (SCT) patients 
upon admission to the SCT unit and again at discharge. Change 
scores were examined to determine whether p ceptions of learn 
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ing needs and priorities changed from admission to discharge. 
Ten SCT patients completed both pre- and post-evaluation sur- 
veys. Results of this study highlight he need for greater attention 
to the psychosocial needs of transplant patients during the pre- 
and post-transplant period. Patients rated psychosocial issues very 
high on importance, but rated the teaching they received to help 
them deal with these concerns as relatively low. More attention 
should be devoted to the psychosocial needs and concerns of 
transplant patients throughout the entire SCT process. Learning 
about complimentary therapies that may be helpful in symptom 
management was not considered important to SCT patients, nor 
did they feel the teaching they r ceived helped them to under- 
stand complimentary therapies. Further study regarding the role 
of complimentary therapy in SCT and how patients are educated 
about these therapies i needed. Patients value knowing as much 
as possible about SCT, but commented that the large quantity of 
complex information limited their ability to retain the information 
they were given about transplantation. Both the timing and 
"dosage" of patient education about SCT requires additional 
study. Educating patients about SCT may be best accomplished in 
small doses with content hat varies across different phases 
throughout the transplant process. 
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SPERM QUALITY ACCORDING TO THE DISEASE AND TREATMENT 
PRE STEM CELL TRANSPLANTATION 
Choi, S/; Kim, t~7, Bok, j.1; Ira, J/; Kim, H. 2 1. St.3/IaJ 7 Hospital, 
Catholic HSCT, Seozd, Korea, South Korea; 2. Catholic University of 
Korea College of Ntr~'sing, Seoul, Korea, Somh Korea. 
Stem ceil transplantation is widely used method for the treat- 
ment of hematological malignancy and offers potential long- 
term survival. But cancer patient has defective sperm and low 
sperm counts a a consequence of the disease and its treatment. 
Irradiation and chemotherapy each compromise fertility by 
exerting cytotoxic effects on gametogenesis. The degree of 
gonadaI effect is governed by the therapeutic regimen(i.e., type, 
dose, schedule) and duration of treatment. This study was eval- 
uated the sperm quality before stem cell transplantation. 
Records of 50 patients with hematological malignance, who 
banked their sperm between Aug. 1998 and Aug. 2001, were 
reviewed. The acute leukemia group had undergone 
chemotherapy or radiation therapy before sperm banking. CML 
group had undergone conservative treatment. Some patients of 
SAA group had got ALG treatment. The sperm quality was 
examined by Volume, MSC(motile sperm count) and Motility. 
60% of all the patients were ol igospermic((20xl06/mL). 
Oligospermia occurred in 72% of the patients in Acute 
leukemia(n=13), 82% in the CML(n=14), and 20% in 
SAA(n=3). Total sperm volume did not differ significantly 
between the three groups. Compared with the other two 
leukemia group, patients in SAA group had higher 
MSC(p=0.0002) and Motility(p=0.0181). Sperm quality of SAA 
did not differ significantly between ALG treatment group and 
no treatment group. In conclusion, sperm quality of the 
leukemia patient who had got chemotherapy or radiation treat- 
ment was poor. The currently preferred practice for patients 
with cancer is to collect sperm before initiation of chemothera- 
py; therefore careful consideration of each individual's case 
must be the rule when determining how long therapy can be 
delayed without jeopardizing the patient's health. As cancer 
therapy may further impair sperm quality, patients hould be 
offered the chance to bank sperm before undergoing cancer 
therapy. 
Motillt>{';}~ ,2 p} Media~IRange~ 
21.5(00 655 igfl2{001811 __~(000021 ~ (0 18144 ¢20 5 )
267 
DEVELOPING A DATA SYSTEM TO MONITOR INFECTIOUS COMPLICA- 
TIONS AND MAKE CLINICAL DECISIONS BASED ON READILY ACCES- 
SIBLE DATA 
ffohm, A.A.; 3/largolese-~lalin, L. A&dt BMT Program, D1dee Uni- 
vers#y ~leclical Centel, Dztrham, NC. 
Susceptibility to infections continues to be a major source of 
morbidity and mortality during the course of hematopoetic cell 
transplantation (HCT). Advances in infection control including 
the use of growth factors, new antibiotics and strategies to prevent 
infections have improved survival rates and outcomes. However, 
resistant bacteria, latent viruses and fungal pathogens continue to 
challenge the success of HCT. As transplant programs investigate 
novel approaches to transplant including the use of reduced inten- 
sity transplants, utilizing alternative donor sources, and experi- 
menting with new agents to prevent or treat GVHD, the pattern 
and timing of pathogens may be altered. Transplant centers moni- 
tor and report infectious complications  a routine basis and 
institute measures to reduce the incidence of serious infections. 
Duke University Medical Center Adult HCT Program has devel- 
oped an integrated ata management system that allows the clini- 
cal staff to review infectious complications in relationship to a 
number of parameters. As the faculty continue to develop novel 
approaches to transplant, reat older patients, manipulate grafts, 
utilize new conditioning regimens and treat different underlying 
diseases, the emergence of opportunistic infections can be not 
only monitored but can also be linked to a number of variables. 
To ensure a comprehensive, authoritative base of information for 
ongoing analysis and review, Duke HCT has arranged for auto- 
mated data feeds from other programs uch as Microbiology, 
Infection Control, and Pulmonary Medicine. Further automation 
merges data from these external sources with Duke HCT own 
internal database. The results are then used to populate a number 
of analysis templates for quarterly review. Correlations and trends 
can be established for any or all of the variables listed above, and 
can be examined from both high level: program as whole, alloge- 
nieic, non-ablative cord blood or autologous transplants, and from 
lower level: by disease, protocol, gender, age, conditioning regi- 
men, and GVHD prophylaxis. Because the data gathering and 
presentation require little manual intervention, the results are 
readily available to clinical and administrative staff. With these 
data in hand, staff can more easily discern statistically significant 
trends and take remedial action quickly and efficiently. 
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ENSURING ACCURACY OF OUTPATIENT MEDICATION ADMINISTRA- 
TION FOR THE PEDIATRIC BONE MARROW TRANSPLANT PATIENT 
l,~an Stelle, J.LJ; Pasut, B/; Endrnd, L.Z; Sickel, A. I 1. The CT~ildrens 
Hospital, Denver, CO; 2. University of Colorado School of lVledicine, 
Denver, CO. 
The Bone Marrow Transplant (BMT) program at The Chil- 
dren's Hospital (TCH) in Denver, Colorado serves patients 
from the Rocky Mountain Area that includes nine states plus 
patients referred from other countries. The patients ages range 
from birth to the late twenties. The transplants are autologous 
and allogenic including matched related, unrelated, and cord 
blood. BMT patients are on between 6 and 20 medications as 
part of their supportive care in the post transplant time period. 
Nurses play a valuable role in educating patients and families of 
the importance and interactions of their medications, evaluat- 
ing compliance issues, and problem-solving roadblocks to suc- 
cessful medication administration. Home medication teaching 
is a multidiseiplinary process involving nurses, pharmacy and 
physicians. The process begins in-patient weeks prior to dis- 
charge and continues at each outpatient clinic visit. We will 
show several tools that help patients with safe medication 
administration. These are available in English and Spanish. 
Tools include: patient/parent medication list including side 
effects, clinic medication tracking list, patient/parent instruc- 
tion form (given with any medication change during the clinic 
visit), patient/parent medication checklist for home use, and 
medication calendars. In spite of this thorough medication 
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